Skip to main content
. 2015 May 4;47(1):122–132. doi: 10.3892/ijo.2015.2982

Figure 5.

Figure 5

Gefitinib/SU11274 combination reduces the level of phospho-RPS6 (S235/236) and RPS6 in TNBC cells. (A and B) Cells were treated with increasing amounts of compounds as indicated for 24 h and western blot analysis was performed with indicated antibodies. β-actin was used as a loading control.